COVID-19 Research Paper Volume 12, Issue 9 pp 7639—7651

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2

class="figure-viewer-img"

Figure 4. The variation trend of chemokines after SARS-CoV treatment 12h, 24h and 48h respectively. (A) Ccl2; (B) Ccl3; (C) Ccl5; (D) Cxcl3; (E) Cxcl5; (F) Cxcl10.